Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $4.53 USD
Change Today +0.1801 / 4.14%
Volume 46.8K
MSLP On Other Exchanges
Symbol
Exchange
OTC US
Berlin
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

muscle pharm corp (MSLP) Snapshot

Open
$4.34
Previous Close
$4.35
Day High
$4.60
Day Low
$4.30
52 Week High
10/8/14 - $14.20
52 Week Low
03/17/15 - $2.78
Market Cap
61.0M
Average Volume 10 Days
35.4K
EPS TTM
$-1.07
Shares Outstanding
13.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MUSCLE PHARM CORP (MSLP)

muscle pharm corp (MSLP) Related Bloomberg News

View More Bloomberg News

muscle pharm corp (MSLP) Related Businessweek News

No Related Businessweek News Found

muscle pharm corp (MSLP) Details

MusclePharm Corporation develops, manufactures, markets, and distributes branded nutritional supplements in the United States and internationally. It offers a range of powders, capsules, tablets, and gels. The company’s MusclePharm Hybrid series products include Assault, Amino1, and Combat Protein Powder; MusclePharm core products comprise BCAA 3:1:2, CLA Core, and Fish Oil that balance the essentials to meet the day-in and day-out demands of athletes; and Arnold Schwarzenegger series physique supplements consist of protein gainers, muscle builders, multivitamins, and nitric oxide boosters. It also provides FitMiss, which is designed and formulated primarily for women lifestyle to cover various needs, including weight loss, multi-vitamins, protein shakes, detox, skin care, and pre-workout energy mixes. In addition, the company offers over-the-counter drugs and preparations, cosmetics, and natural supplements, as well as intends to develop, market, and sell apparel and accessories. MusclePharm Corporation sells its products to various fitness enthusiasts, such as football, combat sports, weight training, bodybuilding, runners, basketball, soccer, cross fit, golf, tennis, and volleyball, as well as outdoor activities, and athletic and recreational enthusiasts. The company was founded in 2008 and is headquartered in Denver, Colorado.

176 Employees
Last Reported Date: 03/16/15
Founded in 2008

muscle pharm corp (MSLP) Top Compensated Officers

Co-Founder, Chairman and Chief Executive Offi...
Total Annual Compensation: $510.0K
President and Director
Total Annual Compensation: $413.0K
Co-Founder and Executive Vice President of Br...
Total Annual Compensation: $310.0K
President of Sales & Marketing
Total Annual Compensation: $450.0K
Compensation as of Fiscal Year 2013.

muscle pharm corp (MSLP) Key Developments

MusclePharm Corporation Reaches Agreement in Principle in SEC Investigation

MusclePharm Corporation announced that it has reached an agreement in principle with the Securities and Exchange Commission (SEC) to resolve an investigation. The company first announced the investigation on September 30, 2013. The SEC Commissioners must still approve the agreement, which was made with the staff of the Enforcement Division of the Denver Regional Office, and thus the terms are not final. Brad Pyatt, the company’s Chief Executive Officer, in his individual capacity, has also reached an agreement `with the Denver Regional Office to resolve the investigation, which agreement is also subject to approval by the SEC Commissioners. The company is also aware that the SEC staff is considering the possibility of proposing that the SEC Commissioners approve charges against certain former officers, in their individual capacity, for violations of the federal securities laws. Under Nevada law, where the company is incorporated, the company may have future obligations to indemnify those individuals for expenses in connection with those investigations and to advance funds to the individuals for those expenses.

Muscle Pharm Corp. Reports Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Sale Guidance for the Year 2015

Muscle Pharm Corp. reported consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported net revenue of $32,672,000 against $37,493,000 a year ago. Loss from operations was $16,400,000 against $5,962,000 a year ago. Loss before provision for income taxes was $16,374,000 against $3,873,000 a year ago. Net loss was $16,236,000 or $1.39 per basic and diluted share against $3,988,000 or $0.45 per basic and diluted share a year ago. Adjusted LBITDA was $9,822,000 against $1,862,000 a year ago. For the year, the company reported net revenue of $177,389,000 against $110,878,000 a year ago. Loss from operations was $19,376,000 against $14,297,000 a year ago. Loss before provision for income taxes was $13,799,000 against $17,603,000 a year ago. Net loss was $13,832,000 or $1.25 per basic and diluted share against $17,718,000 or $2.46 per basic and diluted share a year ago. Adjusted EBITDA was $3,384,000 against $302,000 a year ago. For the year 2015, the company anticipates full-year 2015 net sales in the range of $210 to $220 million, with gross margin in the range of 31% to 33%.

Muscle Pharm Corp. to Report Q4, 2014 Results on Mar 16, 2015

Muscle Pharm Corp. announced that they will report Q4, 2014 results at 5:00 PM, Eastern Standard Time on Mar 16, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MSLP:US $4.53 USD +0.1801

MSLP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Natural Grocers by Vitamin Cottage Inc $26.73 USD +0.03
USANA Health Sciences Inc $128.29 USD +0.17
Vitamin Shoppe Inc $42.98 USD -0.15
View Industry Companies
 

Industry Analysis

MSLP

Industry Average

Valuation MSLP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.3x
Price/Book 2.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MUSCLE PHARM CORP, please visit www.musclepharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.